tiprankstipranks
RenovoRx increases production of FDA-cleared RenovoCath
PremiumThe FlyRenovoRx increases production of FDA-cleared RenovoCath
3M ago
RenovoRx to present on TAMP therapy platform for treatment of LAPC
Premium
The Fly
RenovoRx to present on TAMP therapy platform for treatment of LAPC
3M ago
RenovoRx announces first patient enrolled at UNMC for Phase III TIGeR-PaC trial
Premium
The Fly
RenovoRx announces first patient enrolled at UNMC for Phase III TIGeR-PaC trial
4M ago
RenovoRx initiated with a Buy at Ascendiant
PremiumThe FlyRenovoRx initiated with a Buy at Ascendiant
6M ago
RenovoRx appoints Ryan Witt as SVP, head of corporate strategy, partnerships
Premium
The Fly
RenovoRx appoints Ryan Witt as SVP, head of corporate strategy, partnerships
6M ago
RenovoRx Shareholders Unanimously Elect Board Directors
Premium
Company Announcements
RenovoRx Shareholders Unanimously Elect Board Directors
7M ago
RenovoRx files to sell 6.13M shares of common stock for holders
PremiumThe FlyRenovoRx files to sell 6.13M shares of common stock for holders
8M ago
RenovoRx regains compliance with Nasdaq stockholders’ equity requirement
Premium
The Fly
RenovoRx regains compliance with Nasdaq stockholders’ equity requirement
8M ago
RenovoRx price target lowered to $3.50 from $4 at Alliance Global Partners
Premium
The Fly
RenovoRx price target lowered to $3.50 from $4 at Alliance Global Partners
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100